Skip to main content
. 2021 Apr 1;35(7-8):489–494. doi: 10.1101/gad.345397.120

Figure 5.

Figure 5.

Summary of Peak KO phenotypes and comparison with MeCP2 50% loss (Mecp2flox/y) or MDS mouse model (MECP2-Tg1).